Description: Innovotech Inc. provides practical services and solutions for dealing with medical, agricultural and industrial problems caused by microbial biofilms. The Company is engaged in selling of its products, conducting contract research for outside customers, and research and development to identify products for commercialization. Its products include human and veterinary biofilm susceptibility tests, a seed treatment designed to combat both bacterial and fungal diseases, and an assay used in growing microbial biofilms for research purposes. The Company's lead product, InnovoSIL-1, is a silver-based antimicrobial compound that is not inactivated by chloride (salt) that is present in all body tissues. Its products Agress and AgreGuard are used for agricultural applications to high value crops, such as tomatoes. Its biofilm technology consists of the MBEC Assay and Biofilm Eradication Surface Testing (BEST) Assay, which are used for investigating disinfectants and antimicrobial coatings.
Home Page: www.innovotech.ca
IOT Technical Analysis
2011-94 Street
Edmonton,
AB
T6N 1H1
Canada
Phone:
780 448 0585
Officers
| Name | Title |
|---|---|
| Dr. James Timourian Ph.D. | Chairman, CEO, Pres & Sec. |
| Mr. Alan C. Savage | CFO & Director |
| Dr. Tyler Boone | Chief Operating Officer |
| Dr. Patricia Nadworny | Chief Scientific Officer and Quality & Safety Director |
| Dr. Merle Olson | Scientific Consultant |
Exchange: V
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.1932 |
| Price-to-Sales TTM: | 4.3785 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |